Bioinformatic prediction programs underestimate the frequency of CXCR4 usage by R5X4 HIV type 1 in brain and other tissues

AIDS Research and Human Retroviruses

Volumn 24, Issue 9, 2008, Pages 1215-1220

  Mefford, Megan E ^a   Gorry, Paul R ^b,c   Kunstman, Kevin ^d   Wolinsky, Steven M ^d   Gabuzda, Dana ^a,e  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d NORTHWESTERN UNIVERSITY   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4;

ACCURACY; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALGORITHM; ARTICLE; AUTOPSY; BIOINFORMATICS; CEREBROSPINAL FLUID; DEMENTIA; DNA ISOLATION; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN TISSUE; MALE; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PREDICTION; PRIORITY JOURNAL; R5X4 STRAIN; VIRUS STRAIN;

AIDS DEMENTIA COMPLEX; ALGORITHMS; AMINO ACID SEQUENCE; BRAIN; COMPUTATIONAL BIOLOGY; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; MALE; MOLECULAR SEQUENCE DATA; PHYLOGENY; RECEPTORS, CXCR4; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; SPLEEN; VIRUS INTERNALIZATION;

EID: 51849122551     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2008.0009     Document Type: Article

References (22)

1. Dunfee R, Thomas ER, Gorry PR, et al.: Mechanisms of HIV-1 neurotropism. Curr HIV Res 2006;4:267-278.
2. Ohagen A, Devitt A, Kunstman KJ, et al.: Genetic and functional analysis of full-length human immunodeficiency virus type 1 env genes derived from brain and blood of patients with AIDS. J Virol 2003;77:12336-12345.
3. Gorry PR, Bristol G, Zack JA, et al.: Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity. J Virol 2001;75:10073-10089.
4. Gorry PR, Taylor J, Holm GH, et al.: Increased CCR5 affinity and reduced CCR5/CD4 dependence of a neurovirulent primary human immunodeficiency virus type 1 isolate. J Virol 2002;76:6277-6292.
5. Hoffman TL and Doms RW: HIV-1 envelope determinants for cell tropism and chemokine receptor use. Mol Membr Biol 1999;16:57-65.
6. Cardozo T, Kimura T, Philpott S, et al.: Structural basis for coreceptor selectivity by the HIV type 1 V3 loop. AIDS Res Hum Retroviruses 2007;23:415-426.
7. Resch W, Hoffman N, and Swanstrom R: Improved success of phenotype prediction of the human immunodeficiency virus type 1 from envelope variable loop 3 sequence using neural networks. Virology 2001;288:51-62.
8. Jensen MA, Li FS, van't Wout AB, et al.: Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences. J Virol 2003;77:13376-13388.
9. Low AJ, Dong W, Chan D, et al.: Current V3 genotyping algorithms are inadequate for predicting X4 co-receptor usage in clinical isolates. AIDS 2007;21:F17-24.
10. Xu S, Huang X, Xu H, et al.: Improved prediction of coreceptor usage and phenotype of HIV-1 based on combined features of V3 loop sequence using random forest. J Microbiol 2007;45:441-446.
11. Thomas ER, Dunfee RL, Stanton J, et al.: Macrophage entry mediated by HIV Envs from brain and lymphoid tissues is determined by the capacity to use low CD4 levels and overall efficiency of fusion. Virology 2007;360:105-119.
12. Gray L, Churchill MJ, Keane N, et al.: Genetic and functional analysis of R5X4 human immunodeficiency virus type 1 envelope glycoproteins derived from two individuals homozygous for the CCR5delta32 allele. J Virol 2006;80: 3684-3691.
13. Gorry PR, Dunfee RL, Mefford ME, et al.: Changes in the V3 region of gp120 contribute to unusually broad coreceptor usage of an HIV-1 isolate from a CCR5 delta32 heterozygote. Virology 2007;362:163-178.
14. Bosh VMP: Mutational analysis of the human immunodeficiency virus type I env gene product proteolytic cleavage site. J Virol 1990;64:2337-2344.
15. Shah M, Smit TK, Morgello S, et al.: Env gp120 sequence analysis of HIV type 1 strains from diverse areas of the brain shows preponderance of CCR5 usage. AIDS Res Hum Retroviruses 2006;22:177-181.
16. Hoffman NG, Seillier-Moiseiwitsch F, Ahn J, et al.: Variability in the human immunodeficiency virus type 1 gp120 Env protein linked to phenotype-associated changes in the V3 loop. J Virol 2002;76:3852-3864.
17. Yi Y, Shaheen F, and Collman RG: Preferential use of CXCR4 by R5X4 human immunodeficiency virus type 1 isolates for infection of primary lymphocytes. J Virol 2005;79:1480-1486.
18. Gao F, Morrison SG, Robertson DL, et al.: Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization. J Virol 1996;70:1651-1667.
19. Sullivan PS, Schable C, Koch W, et al.: Persistently negative HIV-1 antibody enzyme immunoassay screening results for patients with HIV-1 infection and AIDS: Serologic, clinical, and virologic results. Seronegative AIDS Clinical Study Group. AIDS 1999;13:89-96.
20. Skrabal K, Saragosti S, Labernardiere JL, et al.: Human immunodeficiency virus type 1 variants isolated from single plasma samples display a wide spectrum of neutralization sensitivity. J Virol 2005;79:11848-11857.
21. van Rij RP, Blaak H, Visser JA, et al.: Differential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytium-inducing HIV-1. J Clin Invest 2000;106:1569.
22. Hu QX, Barry AP, Wang ZX, et al.: Evolution of the human immunodeficiency virus type 1 envelope during infection reveals molecular corollaries of specificity for coreceptor utilization and AIDS pathogenesis. J Virol 2000;74:11858-11872.